Verisante Technology, Inc. belongs to the Health Care sector. Filings by its managers are published through SEDI. From 24 October 2025 to 24 October 2026, the disclosure feed for Verisante Technology, Inc. logged 4 filings by 4 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of Verisante Technology, Inc. for at least a year.
For context, the typical company on the same exchange (median of 2,734 companies) published 14 filings over the same period, against 4 filings here. Since 2022, the database holds 8 purchases and 7 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 29 declarations
Verisante Technology, Inc. is a Canadian company focused on developing cancer detection technologies. It specializes in innovative solutions for the early diagnosis of skin diseases.